Severe thrombocytopenia in myelofibrosis is more prevalent than previously reported
Author:
Funder
CTI Biopharma, Seattle WA, United States
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference5 articles.
1. Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses;Verstovsek;J. Hematol. Oncol.,2017
2. Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis;Masarova;Eur. J. Haematol.,2018
3. Symptom burden profile in myelofibrosis patients with thrombocytopenia: lessons and unmet needs;Scotch;Leuk. Res.,2017
4. Dynamic model for predicting death within 12 months in patients with primary or post–polycythemia vera/essential thrombocythemia myelofibrosis;Tam;J. Clin. Oncol.,2009
5. Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN). Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia;Hernández-Boluda;Br. J. Haematol.,2018
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives;Frontiers in Oncology;2024-07-24
2. A novel application of XPO1 inhibition for the treatment of myelofibrosis;Blood Neoplasia;2024-06
3. Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single‐arm, open‐label, phase 2, multicenter study;American Journal of Hematology;2023-07-19
4. Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials;Blood Advances;2023-07-14
5. Cytopenic myelofibrosis: prevalence, relevance, and treatment;Expert Opinion on Pharmacotherapy;2023-04-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3